Merus to present petosemtamab data for colorectal cancer at conference
PositiveFinancial Markets

Merus is set to present new data on petosemtamab for colorectal cancer at an upcoming conference, highlighting advancements in treatment options for this challenging disease. This presentation is significant as it could pave the way for improved therapies and better outcomes for patients, showcasing Merus's commitment to innovation in oncology.
— Curated by the World Pulse Now AI Editorial System